Phibro Animal Health Corporation (PAHC) P/E Ratio History
Historical price-to-earnings valuation from 2014 to 2026
Loading P/E history...
PAHC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Phibro Animal Health Corporation (PAHC) trades at a price-to-earnings ratio of 36.3x, with a stock price of $43.16 and trailing twelve-month earnings per share of $2.25.
The current P/E is roughly in line with its 5-year average of 37.1x. Over the past five years, PAHC's P/E has ranged from a low of 11.6x to a high of 286.2x, placing the current valuation at the 80th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, PAHC trades at a 62% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
The PEG ratio of 4.85 (P/E divided by 1883% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, PAHC commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PAHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PAHC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $37B | 14.5 | 1.21 | +10% | |
| $45B | 43.7 | 3.06 | +23% | |
| $24B | 49.9 | - | -40% | |
| $11B | 23.8 | - | -41% | |
| $7B | 6.7 | 0.11Best | -1% | |
| $7B | 6.0Lowest | 0.85 | +0% | |
| $157B | 31.4 | 1.92 | +0% | |
| $53B | 49.4 | 4.14 | +23%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PAHC Historical P/E Data (2014–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | Wed Dec 31 2025 00:00:00 GM | $37.36 | $2.25 | 16.6x | -78% |
| FY2026 Q1 | $40.46 | $1.66 | 24.4x | -68% | |
| FY2025 Q4 | Mon Jun 30 2025 00:00:00 GM | $25.54 | $1.18 | 21.6x | -72% |
| FY2025 Q3 | Mon Mar 31 2025 00:00:00 GM | $21.36 | $0.78 | 27.4x | -64% |
| FY2025 Q2 | $21.00 | $0.48 | 43.9x | -43% | |
| FY2025 Q1 | Mon Sep 30 2024 00:00:00 GM | $22.52 | $0.43 | 52.5x | -32% |
| FY2024 Q4 | Sun Jun 30 2024 00:00:00 GM | $16.77 | $0.06 | 286.2x | +273% |
| FY2024 Q3 | Sun Mar 31 2024 00:00:00 GM | $12.93 | $0.32 | 40.4x | -47% |
| FY2024 Q2 | Sun Dec 31 2023 00:00:00 GM | $11.58 | $0.36 | 32.2x | -58% |
| FY2024 Q1 | Sat Sep 30 2023 00:00:00 GM | $12.77 | $0.51 | 25.0x | -67% |
| FY2023 Q4 | Fri Jun 30 2023 00:00:00 GM | $13.70 | $0.81 | 16.9x | -78% |
| FY2023 Q3 | Fri Mar 31 2023 00:00:00 GM | $15.32 | $0.71 | 21.6x | -72% |
Average P/E for displayed period: 76.7x
See PAHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PAHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PAHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPAHC — Frequently Asked Questions
Quick answers to the most common questions about buying PAHC stock.
Is PAHC stock overvalued or undervalued?
PAHC trades at 36.3x P/E, near its 5-year average of 37.1x. The 80th percentile ranking places valuation within normal historical bounds.
How does PAHC's valuation compare to peers?
Phibro Animal Health Corporation P/E of 36.3x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is PAHC's PEG ratio?
PAHC PEG ratio is 4.85. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2014-2026.